{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:0fdbd129-ba9a-454c-bb51-aea7136060eb", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-09-09T17:02:16.877383Z", "firstcreated": "2026-09-09T17:00:14.776238Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "AI-designed drug shows early promise in slowing biological aging", "byline": "Gavin Kendall", "located": "United States", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Cronkite", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Cronkite”. Set rel=canonical to https://cronkite.online/society/ai-designed-drug-shows-early-promise-in-slowing-biological-aging/ when publishing on the web.", "description_text": "A drug developed with artificial intelligence reduced predicted biological age in all 42 trial participants with a lung disease, according to results published in Nature Biotechnology.", "altids": {"mosaic": "0fdbd129-ba9a-454c-bb51-aea7136060eb", "story": "c6a6d992-3c3d-41af-862f-f49f6f593374", "slug": "ai-designed-drug-shows-early-promise-in-slowing-biological-aging"}, "subject": [{"name": "Economy and business", "rel": "direct", "literal": "economy", "code": "medtop:04000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/04000000"}], "place": [{"name": "United States", "literal": "us", "code": "US", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:dccc0d8b-2c78-4cb6-8f55-1e90f26a3d92", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "AI designed a drug that could reverse aging. Early clinical trials are promising", "description_text": "AI-designed drug shows early promise in slowing biological aging", "copyrightholder": "images.fastcompany.com", "copyrightnotice": "AI designed a drug that could reverse aging. Early clinical trials are promising", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "dccc0d8b-2c78-4cb6-8f55-1e90f26a3d92"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "RSS source", "licence_verified_at": "2026-09-09T17:02:16.958931Z", "attribution_required": true, "attribution_text": "AI designed a drug that could reverse aging. Early clinical trials are promising", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "images.fastcompany.com", "source_url": "https://images.fastcompany.com/image/upload/w_1280,q_auto,f_auto,fl_lossy/f_webp,q_auto,c_fit/wp-cms-2/2026/09/p-1-91603598-ai-generated-drug-biological-clock.jpg", "source_page_url": "https://images.fastcompany.com/image/upload/w_1280,q_auto,f_auto,fl_lossy/f_webp,q_auto,c_fit/wp-cms-2/2026/09/p-1-91603598-ai-generated-drug-biological-clock.jpg", "our_page_url": "https://cronkite.online/society/ai-designed-drug-shows-early-promise-in-slowing-biological-aging/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://images.fastcompany.com/image/upload/w_1280,q_auto,f_auto,fl_lossy/f_webp,q_auto,c_fit/wp-cms-2/2026/09/p-1-91603598-ai-generated-drug-biological-clock.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:c6a6d992-3c3d-41af-862f-f49f6f593374", "slug": "ai-designed-drug-shows-early-promise-in-slowing-biological-aging-20260909", "status": "developing", "languages": ["en"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Cronkite", "canonical_required": true, "canonical_url": "https://cronkite.online/society/ai-designed-drug-shows-early-promise-in-slowing-biological-aging/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_borderline", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 3, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.", "independence_check": {"status": "borderline", "score": 0.527, "checked_at": "2026-09-09T17:02:16.948158Z"}}, "wireva:publication": {"name": "Cronkite", "domain": "cronkite.online", "country": "US", "url": "https://cronkite.online/society/ai-designed-drug-shows-early-promise-in-slowing-biological-aging/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/0fdbd129-ba9a-454c-bb51-aea7136060eb", "html": "https://wireva.mib.news/item/0fdbd129-ba9a-454c-bb51-aea7136060eb/ai-designed-drug-shows-early-promise-in-slowing-biological-aging/", "story": "https://wireva.mib.news/story/ai-designed-drug-shows-early-promise-in-slowing-biological-aging-20260909/"}, "wireva:metrics": {"word_count": 433, "char_count": 2902, "reading_time_seconds": 207}}}